Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are an important strategy in cancer therapy. However, with the widespread clinical use of ICIs, people gradually found that ICIs may not be effective enough to eliminate tumor tissue for certain patients. The resistance to ICI treatment makes some...

Descripción completa

Detalles Bibliográficos
Autores principales: Lao, Yefang, Shen, Daoming, Zhang, Weili, He, Rui, Jiang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331941/
https://www.ncbi.nlm.nih.gov/pubmed/35892835
http://dx.doi.org/10.3390/cancers14153575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331941/
https://www.ncbi.nlm.nih.gov/pubmed/35892835
http://dx.doi.org/10.3390/cancers14153575

Ejemplares similares